Dren Bio Revenue and Competitors

Location

#9437

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Dren Bio's estimated annual revenue is currently $12.6M per year.(i)
  • Dren Bio's estimated revenue per employee is $155,000
  • Dren Bio's total funding is $156M.

Employee Data

  • Dren Bio has 81 Employees.(i)
  • Dren Bio grew their employee count by 19% last year.

Dren Bio's People

NameTitleEmail/Phone
1
Chief Operating Officer and Chief Business OfficerReveal Email/Phone
2
COO and CBOReveal Email/Phone
3
SVP Regulatory & QualityReveal Email/Phone
4
EVP, Process Sciences & Manufacturing OperationsReveal Email/Phone
5
VP, Nonclinical DevelopmentReveal Email/Phone
6
Head Strategy and Portfolio ManagementReveal Email/Phone
7
SVP, FinanceReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Associate Director Clinical OperationsReveal Email/Phone
10
Director BiologicsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Dren Bio?

Dren Bio is a San Carlos, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.

keywords:N/A

$156M

Total Funding

81

Number of Employees

$12.6M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dren Bio News

2020-10-19 - Dren Bio Raises $60M in Series A Financing

Dren Bio, Inc., a San Carlos, Calif.-based company developing protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, closed a $60m Series A funding. The round was led by SR One and Taiho Ventures, LLC , with participation from existing inve ...

2020-10-16 - Dren Bio announces a $60M Series A financing

SAN CARLOS, Calif.–(BUSINESS WIRE)–October 16, 2020– Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, announced the closing of a $60 million Series A investment round. The round was led by ...

2020-10-16 - Dren Bio Announces a $60M Series A financing

SAN CARLOS, Calif.--(BUSINESS WIRE)--Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, announced the closing of a $60 million Series A investment round. The round was led by SR One and Taiho ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M820%N/A
#2
$24.8M92-2%N/A
#3
$21.4M1022%N/A
#4
$23.4M103-8%N/A
#5
$16.5M1035%N/A